SecBot SecBot

OPCH

Option Care Health, Inc.
Nasdaq· Services-Home Health Care Services· Inc. DE· CIK 0001014739 Healthcare & Medical Devices
$31.23 +0.01 (+0.03%)
Oct 26 4:00 PM ET · prev $31.22
Market cap
$4.7B
Mid cap
Consensus
Buy
68% Buy or better · 19 analysts
Median target
$32.05
+3% · range $23.00–33.00
Next earnings
Nov 4
in 9 days
1 year
+12.2%
from $27.84 · Oct 27
30 days
+36.4%
from $22.90
52-week range
$19.52–36.59
−15% from high · low May 15
Avg volume 20D
7.28M
Oct 6 spike 65.08M
Short interest
8.56M
≈5.7% of shares · −29.2%
Days to cover
3.5
at average volume
Insider net
+$706.6K
4 buyers · 2 sellers · 12 mo
New fund stakes
1
Q2 2026 13F · 5 exits
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 3 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 4/4 ·Next Earnings date, Nov 4, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersMIXED

    4 insiders bought $1.9M at an average $20.95. 2 insiders sold $1.2M. Price is 49% above their cost.

  • InstitutionsMIXED

    Q2 2026: 40 added (1 new), 29 trimmed or exited. Largest new: Storebrand Asset Management As $14.1M.

  • AnalystsBULLISH

    13 of 19 rate it Buy or better. Median target $32.05 (+3%).

  • Short sellersCOVERING

    Short interest −29.2% to 8.56M shares. 3.5 days to cover, ≈5.7% of shares.

  • TrendUPTREND

    21% above its 50-day average.

Who's buying

13F· Q2 2026
1
new positions
5
exits
$14.1M
in new stakes
FundMoveSharesValue
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD5,980,270$125.4M
DIMENSIONAL FUND ADVISORS LPADD5,449,294$114.3M
MILLENNIUM MANAGEMENT LLCADD2,618,869$54.9M
GOLDMAN SACHS GROUP INCADD2,165,092$45.4M
FMR LLCTRIM1,819,131$38.1M
Point72 Asset Management, L.P.DOUBLED1,800,244$37.8M
CITADEL ADVISORS LLCTRIM1,633,556$34.3M
UBS Group AGADD1,260,195$26.4M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

19 analysts
Buy 68% rate it Buy or better
Strong Buy5Buy8Hold6Sell0Strong Sell0
12-month targets · 8 analysts

Price is inside the target range. Median implies +3%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Oct 9, 2026UBS
DOWNGRADE
DOWNGRADENeutral
Oct 7, 2026William Blair
DOWNGRADE
DOWNGRADEMarket Perform
Oct 7, 2026JP Morgan
DOWNGRADE
DOWNGRADENeutral
Oct 7, 2026Citizens
DOWNGRADE
DOWNGRADEMarket Perform
Oct 7, 2026Jefferies
DOWNGRADE
DOWNGRADEHold
Oct 7, 2026Barrington Research
DOWNGRADE
DOWNGRADEMarket Perform

Insider ledger

Form 4
$1.9M
bought · 4 insiders
$1.2M
sold · 2 insiders
+49.0%
vs their $20.95 cost
DateInsiderTypeValue
Jul 6, 2026
Bhatia Prateek
EVP Sp Sales & Solutions
AWARD16,386 sh
Jul 6, 2026
Bhatia Prateek
EVP Sp Sales & Solutions
AWARD23,409 sh
May 20, 2026
BRANDT ERIC
Director
AWARD$58.8K
May 20, 2026
SULLIVAN TIMOTHY P
Director
AWARD$107.5K
May 20, 2026
KRAEMER HARRY M JANSEN JR
Director
AWARD$268.5K
May 20, 2026
Deckmann Natasha
Director
AWARD$18.8K
May 20, 2026
BRANDT ERIC
Director
AWARD8,997 sh
May 20, 2026
Wright Norman L.
Director
AWARD8,997 sh

Earnings setup

Estimates
Nov 4
reports in 9 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
8,560,769
shares short
-29.2%
vs prior settlement
3.5
days to cover
≈5.7%
of shares outstanding
Trading halts
Oct 6, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 6, 2026 SEC
Option Care Health filed DEFA14A soliciting materials in connection with its pending acquisition by CD&R and McKesson…
DEFA14A — Impact 3/10
Oct 6, 2026 SEC
Option Care Health (OPCH) has entered into a definitive merger agreement to be acquired by an investor group led by…
DEFA14A — Impact 7/10
Oct 6, 2026 SEC
Option Care Health has entered into a definitive agreement to be acquired by an investor group led by CD&R (majority…
8-K — Impact 7/10
Oct 6, 2026 Trading halt
Halt Resumed: OPCH — trading resumed after T3 (News and Resumption Times)
Halted 2026-10-06T11:55:00.000Z | Resumed 2026-10-06T12:20:00.000Z
Jul 6, 2026 Insider
Bhatia Prateek was granted 16,386 shares
EVP Sp Sales & Solutions
Jul 6, 2026 Insider
Bhatia Prateek was granted 23,409 shares
EVP Sp Sales & Solutions
Jun 30, 2026 Inst.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — ADD
5,980,270 shares ($125.4M)
Jun 30, 2026 Inst.
DIMENSIONAL FUND ADVISORS LP — ADD
5,449,294 shares ($114.3M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

SecBot reports

11 filings · 1 press release · 3 bullish · 0 bearish · 1 mixed · 7 neutral
All OPCH filing & press-release reports (12)